Macrophage responses are skewed toward a phenotype that produces less proinflammatory TNFα and profibrotic TGFβ, thereby is less able to support NAFLD development and progression to NASH (Dey et al., 2014). The gene discussed is TGFB1; the disease is metabolic dysfunction-associated steatohepatitis.